Scouted selects products independently. If you purchase something from our posts, we may earn a small commission.
If you frequent a cosmetic dermatologist for regularly scheduled neurotoxin wrinkle relaxers (Botox, Dysport, etc.), the odds are high that you’ve already heard about Sculptra from your derm or aesthetic injector. Sculptra (poly-L-lactic acid) is an injectable bio-stimulatory dermal filler touted for gradually addressing volume loss and yielding more natural results than hyaluronic acid-based fillers like Juvederm and Restalyne. Sculptra was approved by the FDA for addressing facial fat loss back in 2004 (primarily for those suffering from HIV and AIDS-induced facial lipoatrophy), but 20 years later, the collagen-and-elastin-boosting injectable treatment is surging in popularity seemingly all of a sudden.
Experts attribute several factors to Sculptra’s swift rise to fame over the last few years, but one of the main reasons is increased patient education in cosmetic treatments and an overwhelming backlash against hyaluronic acid-based fillers. These conventional fillers, which offer instant results post-treatment and last anywhere from six months to several years, have recently garnered a tidal wave of negative PR due to the potential of migration, unnatural-looking results, causing complications for surgical cosmetic procedures like facelifts down the road, and interference with the lymphatic system.
